New Research on Global Recombinant Protein Market Highlights Growth Overview and Estimates Market Size by 2022

With a prime focus on recombinant protein industry, research analysts of FactMR has publicized a comprehensive study to its online repository. This in-depth study is headlined as “Recombinant Protein Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” which discusses the historic and current scenario of the global market, along with the future prospects it holds for a 5 year assessment period, 2017-2022. For the benefit of the investors of the report, this research focuses on the drivers and restraints anticipated to impact the demand for recombinant protein in the coming years. Along with these insights, the report provides the readers crucial insights on the strategies implemented by leading companies to remain in the lead of this competitive market.

6 Key Estimations on Future of Global Recombinant Protein Market

1. Basic research will remain the largest application segment in the global recombinant proteins market. Revenues from basic research will reach roughly US$ 270 Mn in revenues by the end of 2022.

2. Toxicity screening, and drug discovery & development will witness the fastest expansion through 2022, based on application of recombinant proteins.

3. Recombinant protein sales for forensic testing application will exhibit the lowest CAGR in the market through 2022.

Request Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=186

4. North America is projected to remain dominant in the global market for recombinant proteins, with sales poised to account for approximately US$ 150 Mn revenues by 2022-end.

5. Europe will continue to be the second largest market for recombinant proteins over the forecast period.

6. The market for recombinant protein in Middle East & Africa (MEA) will exhibit a sluggish expansion through 2022.

North America to Remain Dominant in the Market

North America will continue to retain its dominance in the global recombinant protein market, with sales projected to reach nearly US$ 150 Mn by 2022-end. Europe is estimated to be the second most lucrative market for recombinant protein throughout the forecast period. The market in Middle East & Africa (MEA) is anticipated to witness a sluggish expansion through 2022.

Browse Full Report with TOC- https://www.factmr.com/report/186/recombinant-protein-market

Recombinant proteins factoring molecular growth will remain the most lucrative product in the market, followed by checkpoint regulators. In addition, sales of growth factors, and cytokines are poised to exhibit similar CAGRs through 2022. However, sales of chemokines are estimated to register the fastest expansion through 2022. Demand for enzymes & inhibitors will continue to be sluggish throughout the forecast period.

Although academic & research institutes are expected to remain the largest end-users of recombinant proteins in terms of revenues, sales in biopharmaceutical companies will register the highest CAGR compared to all the other end-user segments through 2022. Revenues from sales of recombinant proteins in academic & research institutes will account for over one-third market share during 2017 to 2022.

Recombinant proteins will continue to find the largest application in basic research activities. Revenues from recombinant proteins for basic research are expected to account for around US$ 270 Mn by 2022-end. Drug discovery & development, and toxicity screening are estimated to emerge as the fastest growing applications of recombinant proteins. Sales of recombinant proteins for application in forensic testing are estimated to register the lowest CAGR through 2022.

Buy this Report- https://www.factmr.com/checkout/186/S

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

FactMR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.